Heart-After-Liver Transplantation Attenuates Rejection of Cardiac Allografts in Sensitized Patients.

[1]  Y. Woo,et al.  Short‐term outcomes of en bloc combined heart and liver transplantation in the failing Fontan , 2019, Clinical transplantation.

[2]  J. Kobashigawa,et al.  Sensitization in Heart Transplantation: Emerging Knowledge: A Scientific Statement From the American Heart Association. , 2019, Circulation.

[3]  J. Wetzels,et al.  Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab , 2019, Clinical Pharmacokinetics.

[4]  M. Stegall,et al.  Donor-specific hypo-responsiveness occurs in simultaneous liver-kidney transplant recipients after the first year. , 2018, Kidney international.

[5]  L. Potena,et al.  The management of antibodies in heart transplantation: An ISHLT consensus document. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  M. Stegall,et al.  Unique molecular changes in kidney allografts after simultaneous liver-kidney compared with solitary kidney transplantation. , 2017, Kidney international.

[7]  D. Mancini,et al.  Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[8]  K. Mandal,et al.  The Paradoxical Relationship Between Donor Distance and Survival After Heart Transplantation. , 2017, The Annals of thoracic surgery.

[9]  J. Kobashigawa,et al.  Calculated panel-reactive antibody predicts outcomes on the heart transplant waiting list. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[10]  M. Stegall,et al.  Liver Allograft Provides Immunoprotection for the Cardiac Allograft in Combined Heart–Liver Transplantation , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[11]  J. Patel,et al.  Desensitization strategies in adult heart transplantation-Will persistence pay off? , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[12]  M. Stegall,et al.  Decreased chronic cellular and antibody-mediated injury in the kidney following simultaneous liver-kidney transplantation. , 2016, Kidney international.

[13]  P S Heeger,et al.  Multicenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation‐05 Study , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  H. Ross,et al.  Outcomes in adult congenital heart disease patients undergoing heart transplantation: A systematic review and meta-analysis. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  Jessica L. Howard,et al.  Combined heart and liver transplantation can be safely performed with excellent short- and long-term results. , 2014, The Annals of thoracic surgery.

[16]  M. Stegall,et al.  Antibody‐mediated rejection in liver transplantation: Current controversies and future directions , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[17]  A. Angelini,et al.  The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  F. Fallani,et al.  Occurrence of Fatal and Nonfatal Adverse Outcomes after Heart Transplantation in Patients with Pretransplant Noncytotoxic HLA Antibodies , 2013, Journal of transplantation.

[19]  R. Rodeheffer,et al.  Combined Heart and Liver Transplant Attenuates Cardiac Allograft Vasculopathy Compared with Isolated Heart Transplantation , 2013, Transplantation.

[20]  J. Heimbach,et al.  Combined heart and liver transplantation: protection of the cardiac graft from antibody rejection by initial liver implantation. , 2013, Transplantation.

[21]  K. Kokko,et al.  Donor‐Directed MHC Class I Antibody Is Preferentially Cleared from Sensitized Recipients of Combined Liver/Kidney Transplants , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  E. Reed,et al.  The long‐term outcome of treated sensitized patients who undergo heart transplantation , 2011, Clinical transplantation.

[23]  Clive Lewis,et al.  The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[24]  W. Kremers,et al.  Combined Heart and Liver Transplantation: A Single-Center Experience , 2009, Transplantation.

[25]  M. Oz,et al.  The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the United Network for Organ Sharing database. , 2007, The Journal of thoracic and cardiovascular surgery.

[26]  L. Mjörnstedt,et al.  Successful Combined Partial Auxiliary Liver and Kidney Transplantation in Highly Sensitized Cross‐Match Positive Recipients , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[27]  M. Stegall,et al.  A Comparison of Plasmapheresis Versus High‐Dose IVIG Desensitization in Renal Allograft Recipients with High Levels of Donor Specific Alloantibody , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[28]  S. Dunlap,et al.  The Presence of HLA-Directed Antibodies after Heart Transplantation Is Associated with Poor Allograft Outcome , 2005, Transplantation.

[29]  J. Narula,et al.  Outcomes in recipients of combined heart-kidney transplantation: multiorgan, same-donor transplant study of the International Society of Heart and Lung Transplantation/United Network for Organ Sharing Scientific Registry. , 1997, Transplantation.

[30]  C. Delaney,et al.  Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. , 1995, Transplantation.

[31]  R. Calne,et al.  Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival. , 1995, Transplantation.

[32]  T. Starzl,et al.  Microchimerism, dendritic cell progenitors and transplantation tolerance , 1995, Stem cells.

[33]  P. Gane,et al.  Specific absorption of lymphocytotoxic alloantibodies by the liver in inbred rats. , 1990, Transplantation.

[34]  B. Roser,et al.  Reversal of transplantation immunity by liver grafting , 1981, Nature.